All In MedTech

Device Trial Radar · NCT02946840

The Use of a New Core Needle in the Endoscopic Ultrasound Assisted Tissue Sampling for Pancreatic Solid Masses

Last checked: Nov 19, 2026Latest source record: Aug 8, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

100

Actual

Start

Aug 2016

Primary completion

May 2017

Study completion May 2018

Sponsor

Lead sponsor
Istituto Clinico HumanitasAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Maggiore Bellaria Hospital, Bologna; Catholic University of the Sacred Heart; The Mediterranean Institute for Transplantation and Advanced Specialized Therapies; Azienda Ospedaliera Universitaria Integrata Verona; Azienda Unità Sanitaria Locale di Imola
First posted
Oct 27, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) is a reliable, safe, and effective technique for obtaining samples from pancreatic masses. A new core biopsy needle has been developed by Beacon bnx® (Medtronic, Newton, MA) that allows the possibility to achieve a core for histology evaluation and the interchangibility of needle size using the same needle shelter and different needle sizes.

Conditions

  • Pancreatic Masses

Interventions

  • FNA with 25 G Beacon needleDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Core acquisitionTime frame: 24 h

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Endoscopy Unit, Humanitas Research Hospital

    Rozzano, Milano, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.